Hamaguchi Y, Juhn S K, Morizono T
Department of Otolaryngology, University of Minnesota School of Medicine, Minneapolis.
Acta Otolaryngol Suppl. 1989;457:124-8. doi: 10.3109/00016488809138894.
By using an antigen-induced (Arthus) otitis media (OM) model in chinchillas sensitized with human serum albumin (HSA), we investigated the passage of HSA through the round window membrane (RWM) by measuring HSA levels in both the middle ear fluid (MEF) and the perilymph (PL). The effect of corticosteroid treatment on HSA passage was also studied. Mean HSA levels in both the MEF and the PL were proportional to the HSA dose administered (0.5, 5, 50 mg/ml). The proportion of HSA-positive PL samples was significantly lower in the sensitized group than that of the control (p less than 0.01). HSA levels in the PL appear to depend on HSA levels in the MEF, which were significantly depressed in the sensitized animals. These results suggest that an immunological reaction may be involved in the reduction of antigen (HSA) passage through the RWM by reducing antigen concentrations in the MEF. Corticosteroid treatment reduces the passage of HSA into the PL in non-sensitized animals.
通过在用人血清白蛋白(HSA)致敏的栗鼠中使用抗原诱导(阿瑟斯)中耳炎(OM)模型,我们通过测量中耳液(MEF)和外淋巴(PL)中的HSA水平,研究了HSA通过圆窗膜(RWM)的情况。还研究了皮质类固醇治疗对HSA通过的影响。MEF和PL中的平均HSA水平与给药的HSA剂量(0.5、5、50mg/ml)成正比。致敏组中HSA阳性PL样本的比例明显低于对照组(p<0.01)。PL中的HSA水平似乎取决于MEF中的HSA水平,而致敏动物的MEF中的HSA水平明显降低。这些结果表明,免疫反应可能通过降低MEF中的抗原浓度参与减少抗原(HSA)通过RWM的过程。皮质类固醇治疗可减少未致敏动物中HSA进入PL的量。